Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
41.8M
-
Shares change
-
+6.04M
-
Total reported value, excl. options
-
$218M
-
Value change
-
+$36.4M
-
Put/Call ratio
-
1.07
-
Number of buys
-
46
-
Number of sells
-
-57
-
Price
-
$5.20
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2017
143 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2017.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.8M shares
of 295M outstanding shares and own 14.2% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (7.06M shares), BlackRock Inc. (5.62M shares), BAKER BROS. ADVISORS LP (4.53M shares), VANGUARD GROUP INC (3.09M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3M shares), FMR LLC (1.61M shares), STATE STREET CORP (1.23M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.03M shares), FIC CAPITAL INC (941K shares), and NORTHERN TRUST CORP (903K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.